TMEM267
Transmembrane protein 267
Also known as: C5orf28, FLJ21657, TM267_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q0VDI3
- Gene
- TMEM267
- Ensembl
- ENSG00000151881
- Chromosome
- 5
- Canonical length
- 215 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
215 residues, UniProt reviewed canonical sequence.
>Q0VDI3|TMEM267
1 MASETEKTHA LLQTCSTESL ISSLGLGAFC LVADRLLQFS TIQQNDWLRA LSDNAVHCVI
61 GMWSWAVVTG IKKKTDFGEI ILAGFLASVI DVDHFFLAGS MSLKAALTLP RRPFLHCSTV
121 IPVVVLTLKF TMHLFKLKDS WCFLPWMLFI SWTSHHIRDG IRHGLWICPF GKTSPLPFWL
181 YVIITSSLPH ICSFVMYLTG TRQMMSSKHG VRIDVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM267 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 36 nTPM
- breast: 14 nTPM
- epididymis: 11 nTPM
- cervix: 10 nTPM
- parathyroid gland: 10 nTPM
- skin: 9.8 nTPM
Single-cell type
- sertoli cells: 118 nCPM
- hepatic stellate cells: 65 nCPM
- cytotrophoblasts: 61 nCPM
- breast lactating cells: 60 nCPM
- mucous neck cells: 60 nCPM
- b-cells: 58 nCPM
Immune cell
- MAIT T-cell: 22 nTPM
- naive CD4 T-cell: 20 nTPM
- memory CD4 T-cell: 20 nTPM
- NK-cell: 19 nTPM
- T-reg: 18 nTPM
- basophil: 17 nTPM
Brain region
- choroid plexus: 13 nTPM
- midbrain: 12 nTPM
- pons: 12 nTPM
- hypothalamus: 11 nTPM
- medulla oblongata: 11 nTPM
- white matter: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.79
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transmembrane protein 267
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM267 as an antibody target. Whether an autoantibody or antibody against TMEM267 could matter depends on whether native TMEM267 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM267 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM267 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...